Back to search

Belgium· BE-AMP-SAM028567-00

Sulfarlem S 25 25 mg

A anethole trithione product containing anethole trithione, registered in Belgium by EG. The same ATC class is registered in 4 of our 19 countries.

ATC A16AX02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedSulfarlem S 25 25 mgATCA16AX02REGISTER NO.BE-AMP-SAM028567-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Anethole trithione is registered in 4 of 19 countries.

Countries holding a registration under ATC A16AX02 (anethole trithione), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose

Anethole trithione · ATC A16AX02

4 / 19 countries

  • Belgiumprice
  • Canada
  • Franceprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Anethole Trithione
Manufacturer
EG
Country
Belgium (BE)
ATC code
A16AX02
ATC class
Anethole trithione
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0131375

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Anethole trithione in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All anethole trithione products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • France · Sulfarlem, Sulfarlem S
  • Luxembourg · Sulfarlem S25

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/92a9a794-6d1a-4d81-8cf0-ece827d76d04
GET /v1/drugs/92a9a794-6d1a-4d81-8cf0-ece827d76d04?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Sulfarlem S 25 25 mg",
  "name_fr": "Sulfarlem S 25 25 mg",
  "name_nl": "Sulfarlem S 25 25 mg",
  "amp_code": "SAM028567-00",
  "strengths": [
    "25.0000",
    "25.0000",
    "0.0445",
    "0.0055",
    "6.0000",
    "8.5000"
  ],
  "pack_count": 1,
  "substances": [
    "Anethole Trithione",
    "E 110",
    "E 124",
    "Lactose Monohydrate",
    "Wheat Starch"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Anethole Trithione",
  "authorisation_numbers": [
    "BE028567"
  ]
}

See everything about anethole trithione.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.